Skip to content

Clinical trials

Phase 2 Dwarfism, Pituitary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dwarfism, Pituitary Phase: Phase 2 Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20052
20063
20072
20083
20091
20103
20112
20132
20142
20152
20162
20171
20191
20201
20211
20221
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated7
Recruiting3
Unknown status2
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Lumos Pharma4
Changchun GeneScience Pharmaceutical Co., Ltd.3
Altus Pharmaceuticals2
Ascendis Pharma A/S2
Federico II University2
Genexine, Inc.2
OPKO Health, Inc.2
Pfizer2
University of Pennsylvania2
Versartis Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dwarfism, Pituitary36
Hypopituitarism2
Brain Concussion1
Brain Injuries, Traumatic1
Cognition Disorders1
Dwarfism1
Fibromyalgia1
Heart Failure1
Hypogonadism1
Myocardial Ischemia1

Trials

Showing 26 to 36 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.